Home › Funds › Artia Global Partners LP › UTHR
Artia Global Partners LP position in UTHR
UNITED THERAPEUTICS CORP DEL · Health Care
Artia Global Partners LP reported holding 5,000 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q2 2026 13F filing — a position valued at US$2.7M, representing 0.50% of its reported portfolio and ranking #39 among its reported holdings. Artia Global Partners LP has disclosed UTHR holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Artia Global Partners LP's UTHR position evolved
Artia Global Partners LP first disclosed a stake in UTHR in Q1 2025 at 5,000 shares (US$1.5M). The position peaked in Q1 2026 at 5,000 shares, worth US$3.0M. Across 6 filings, Artia Global Partners LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 5,000 shares valued at US$2.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 5.00K | $1.54M | New |
| Q2 2025 | 5.00K | $1.44M | Hold |
| Q3 2025 | 5.00K | $2.10M | Hold |
| Q4 2025 | 5.00K | $2.44M | Hold |
| Q1 2026 | 5.00K | $2.96M | Hold |
| Q2 2026 | 5.00K | $2.71M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About UTHR and 13F data
UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 43 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), Renaissance Technologies (US$925.8M), ASSETMARK, INC (US$338.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding UTHR
- Avoro Capital Advisors LLC 2.78M sh · $1.51B · Q2 2026
- Renaissance Technologies 1.71M sh · $925.85M · Q2 2026
- ASSETMARK, INC 624.07K sh · $338.14M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 457.00K sh · $247.62M · Q2 2026
- Vestal Point Capital, LP 435.00K sh · $235.70M · Q2 2026
- Eversept Partners, LP 287.67K sh · $155.87M · Q2 2026
More on Artia Global Partners LP
FAQ
How long has Artia Global Partners LP held UTHR?
Artia Global Partners LP has disclosed UTHR holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is Artia Global Partners LP's current position in UTHR?
As of Q2 2026, Artia Global Partners LP holds 5.00K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $2.71M, representing 0.50% of its reported portfolio and ranking #39.
Has Artia Global Partners LP been buying or selling UTHR?
In the latest 13F filing (Q2 2026), Artia Global Partners LP held unchanged its position in UTHR. The position peaked in Q1 2026 at 5.00K shares.
Which other funds hold UTHR?
Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.